Page last updated: 2024-10-24

chlorambucil and Dry Eye

chlorambucil has been researched along with Dry Eye in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research Excerpts

ExcerptRelevanceReference
"Waldenström's macroglobulinemia is an uncommon cause of dry eye."1.29Dry eye in Waldenström's macroglobulinemia. Improvement after systemic chemotherapy. ( Cordido, M; Fernández-Lago, C; Fernández-Vigo, J; López-Nieto, C, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cordido, M1
Fernández-Lago, C1
Fernández-Vigo, J1
López-Nieto, C1

Other Studies

1 other study available for chlorambucil and Dry Eye

ArticleYear
Dry eye in Waldenström's macroglobulinemia. Improvement after systemic chemotherapy.
    Cornea, 1995, Volume: 14, Issue:2

    Topics: Chlorambucil; Drug Therapy, Combination; Dry Eye Syndromes; Humans; Lacrimal Apparatus; Male; Middle

1995